Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Clostridium Infections | 6 | 2018 | 595 | 1.84 | Why? |
| Entamoeba histolytica | 1 | 2018 | 22 | 0.75 | Why? |
| Gastroenteritis | 3 | 2018 | 489 | 0.73 | Why? |
| Neoplasms | 14 | 2021 | 17251 | 0.73 | Why? |
| Salmonella | 1 | 2018 | 58 | 0.71 | Why? |
| Whooping Cough | 1 | 2020 | 201 | 0.69 | Why? |
| Bacterial Toxins | 2 | 2018 | 185 | 0.66 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2018 | 323 | 0.55 | Why? |
| Immunocompromised Host | 4 | 2019 | 5150 | 0.52 | Why? |
| Surgical Wound Infection | 1 | 2018 | 501 | 0.48 | Why? |
| Cross Infection | 4 | 2021 | 8675 | 0.44 | Why? |
| Digestive System Surgical Procedures | 1 | 2018 | 677 | 0.43 | Why? |
| Immunization Schedule | 1 | 2018 | 1305 | 0.43 | Why? |
| Sentinel Surveillance | 1 | 2017 | 1093 | 0.40 | Why? |
| Hematopoietic Stem Cell Transplantation | 5 | 2021 | 2426 | 0.39 | Why? |
| Ultraviolet Rays | 1 | 2018 | 1272 | 0.37 | Why? |
| Cancer Care Facilities | 4 | 2021 | 1190 | 0.37 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.36 | Why? |
| Hematologic Neoplasms | 1 | 2021 | 2105 | 0.35 | Why? |
| Virology | 1 | 2012 | 489 | 0.35 | Why? |
| Tuberculosis, Pulmonary | 1 | 2017 | 1171 | 0.32 | Why? |
| New York City | 6 | 2021 | 7432 | 0.32 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.32 | Why? |
| Disinfection | 2 | 2020 | 2912 | 0.30 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.27 | Why? |
| Colorectal Neoplasms | 1 | 2018 | 1884 | 0.27 | Why? |
| Electronic Health Records | 1 | 2017 | 3492 | 0.26 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.26 | Why? |
| Molecular Diagnostic Techniques | 3 | 2020 | 4239 | 0.23 | Why? |
| Feces | 4 | 2018 | 4235 | 0.21 | Why? |
| Health Status Disparities | 1 | 2018 | 4072 | 0.20 | Why? |
| Strategic Planning | 1 | 2021 | 122 | 0.20 | Why? |
| Adoptive Transfer | 1 | 2020 | 250 | 0.20 | Why? |
| Bordetella pertussis | 1 | 2020 | 117 | 0.19 | Why? |
| Paronychia | 1 | 2018 | 1 | 0.19 | Why? |
| Vaccines | 1 | 2018 | 3692 | 0.19 | Why? |
| Viruses | 1 | 2012 | 2238 | 0.18 | Why? |
| Colony Count, Microbial | 1 | 2018 | 177 | 0.18 | Why? |
| Mycobacterium tuberculosis | 2 | 2018 | 1164 | 0.18 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.18 | Why? |
| Vancomycin-Resistant Enterococci | 1 | 2018 | 104 | 0.17 | Why? |
| Contact Tracing | 1 | 2017 | 8448 | 0.17 | Why? |
| Skin Diseases, Bacterial | 1 | 2018 | 105 | 0.16 | Why? |
| Molecular Typing | 1 | 2018 | 280 | 0.16 | Why? |
| Leukocyte L1 Antigen Complex | 1 | 2018 | 238 | 0.16 | Why? |
| Coinfection | 1 | 2016 | 6820 | 0.16 | Why? |
| Measles-Mumps-Rubella Vaccine | 1 | 2019 | 282 | 0.15 | Why? |
| Immunotherapy, Adoptive | 1 | 2021 | 524 | 0.15 | Why? |
| Adenovirus Infections, Human | 1 | 2017 | 145 | 0.15 | Why? |
| Mouth | 1 | 2020 | 622 | 0.15 | Why? |
| Bacteriological Techniques | 1 | 2018 | 239 | 0.15 | Why? |
| Adenoviruses, Human | 1 | 2017 | 195 | 0.15 | Why? |
| Immunoenzyme Techniques | 1 | 2017 | 448 | 0.15 | Why? |
| Bone Marrow Transplantation | 1 | 2018 | 343 | 0.15 | Why? |
| Interrupted Time Series Analysis | 1 | 2018 | 868 | 0.14 | Why? |
| Rectum | 1 | 2018 | 495 | 0.14 | Why? |
| Virus Diseases | 1 | 2012 | 3779 | 0.14 | Why? |
| Fungi | 1 | 2018 | 471 | 0.14 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2018 | 449 | 0.14 | Why? |
| Nose | 1 | 2020 | 1093 | 0.13 | Why? |
| Oncology Service, Hospital | 1 | 2017 | 314 | 0.13 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 2 | 2021 | 1316 | 0.13 | Why? |
| Patients' Rooms | 1 | 2018 | 675 | 0.13 | Why? |
| Policy | 1 | 2021 | 1372 | 0.13 | Why? |
| Norovirus | 1 | 2017 | 294 | 0.13 | Why? |
| Tertiary Healthcare | 1 | 2017 | 616 | 0.13 | Why? |
| Humans | 28 | 2021 | 930598 | 0.12 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.12 | Why? |
| False Positive Reactions | 1 | 2018 | 1338 | 0.12 | Why? |
| Vaccination | 1 | 2018 | 19050 | 0.12 | Why? |
| Oropharynx | 1 | 2020 | 1581 | 0.12 | Why? |
| Databases, Factual | 2 | 2018 | 6248 | 0.12 | Why? |
| Measles | 1 | 2019 | 608 | 0.11 | Why? |
| United States | 6 | 2021 | 46150 | 0.11 | Why? |
| Respiratory Tract Infections | 1 | 2012 | 6817 | 0.11 | Why? |
| New York | 1 | 2018 | 2488 | 0.10 | Why? |
| Operating Rooms | 1 | 2020 | 1841 | 0.10 | Why? |
| Risk Factors | 4 | 2020 | 71621 | 0.09 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2017 | 1439 | 0.09 | Why? |
| Adult | 10 | 2021 | 244371 | 0.09 | Why? |
| Female | 15 | 2021 | 380317 | 0.09 | Why? |
| Male | 14 | 2021 | 367725 | 0.09 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.09 | Why? |
| Aged | 9 | 2021 | 215776 | 0.09 | Why? |
| Clinical Decision-Making | 2 | 2020 | 3755 | 0.09 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.09 | Why? |
| Allografts | 2 | 2021 | 761 | 0.08 | Why? |
| Bacteria | 1 | 2018 | 1897 | 0.08 | Why? |
| Recurrence | 1 | 2016 | 3675 | 0.08 | Why? |
| Polymerase Chain Reaction | 2 | 2018 | 6740 | 0.08 | Why? |
| Logistic Models | 2 | 2018 | 9089 | 0.08 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.07 | Why? |
| Pediatrics | 1 | 2021 | 2969 | 0.07 | Why? |
| Clinical Laboratory Techniques | 1 | 2012 | 23402 | 0.07 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.07 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.07 | Why? |
| Immunologic Factors | 1 | 2020 | 4206 | 0.07 | Why? |
| Time-to-Treatment | 1 | 2021 | 5883 | 0.07 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2018 | 3388 | 0.06 | Why? |
| Nursing Staff, Hospital | 1 | 2017 | 1554 | 0.06 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.06 | Why? |
| Communicable Diseases | 1 | 2017 | 2148 | 0.06 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.06 | Why? |
| Myelodysplastic-Myeloproliferative Diseases | 1 | 2021 | 39 | 0.06 | Why? |
| Tuberculosis | 1 | 2018 | 2895 | 0.06 | Why? |
| Genotype | 3 | 2018 | 4697 | 0.06 | Why? |
| Autografts | 1 | 2020 | 78 | 0.06 | Why? |
| Neoplasm, Residual | 1 | 2021 | 147 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.05 | Why? |
| Specimen Handling | 1 | 2018 | 6190 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2018 | 3633 | 0.05 | Why? |
| Transplantation, Autologous | 1 | 2021 | 364 | 0.05 | Why? |
| Anemia, Aplastic | 1 | 2021 | 167 | 0.05 | Why? |
| Histological Techniques | 1 | 2018 | 35 | 0.05 | Why? |
| Amyloidosis | 1 | 2021 | 178 | 0.05 | Why? |
| Taxoids | 1 | 2018 | 45 | 0.05 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.04 | Why? |
| Hospitals | 1 | 2018 | 11793 | 0.04 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.04 | Why? |
| Dermatomycoses | 1 | 2018 | 55 | 0.04 | Why? |
| Paclitaxel | 1 | 2018 | 124 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2021 | 15978 | 0.04 | Why? |
| Antineoplastic Agents, Phytogenic | 1 | 2018 | 183 | 0.04 | Why? |
| Cell- and Tissue-Based Therapy | 1 | 2020 | 422 | 0.04 | Why? |
| Leukemia | 1 | 2021 | 598 | 0.04 | Why? |
| Sensitivity and Specificity | 2 | 2018 | 22971 | 0.04 | Why? |
| Italy | 1 | 2020 | 38444 | 0.04 | Why? |
| Disease-Free Survival | 1 | 2020 | 1654 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Evidence-Based Practice | 1 | 2021 | 693 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Child | 4 | 2021 | 70012 | 0.03 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Disease Outbreaks | 2 | 2018 | 27595 | 0.03 | Why? |
| Child, Preschool | 2 | 2017 | 36283 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.03 | Why? |
| Limit of Detection | 1 | 2018 | 2698 | 0.02 | Why? |
| Cluster Analysis | 1 | 2018 | 3001 | 0.02 | Why? |
| Resource Allocation | 1 | 2021 | 1771 | 0.02 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.02 | Why? |
| Infant | 1 | 2012 | 30274 | 0.02 | Why? |
| Civil Defense | 1 | 2021 | 1687 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Aged, 80 and over | 1 | 2017 | 88759 | 0.02 | Why? |
| Diarrhea | 1 | 2018 | 2743 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Societies, Medical | 1 | 2019 | 6907 | 0.02 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.01 | Why? |
| Triage | 1 | 2021 | 7151 | 0.01 | Why? |
| Medical Oncology | 1 | 2018 | 3826 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.01 | Why? |
| Infection Control | 2 | 2021 | 23131 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Retrospective Studies | 2 | 2020 | 105322 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.01 | Why? |
Kamboj's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(164)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(121)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_